During the past decade, Bluewater Clinical Research Group Inc conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 14 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bluewater Clinical Research Group Inc" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Dynogen Pharmaceuticals" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Mannkind Corporation" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bluewater Clinical Research Group Inc" #1 collaborator was "PPD" with 2 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bluewater Clinical Research Group Inc" are "Obesity" (4 trials), "Alzheimer Disease" (3 trials), "Cardiovascular Disease" (3 trials), "Irritable Bowel Syndrome" (3 trials) and "Migraine" (3 trials). Many other conditions were trialed in "Bluewater Clinical Research Group Inc" in a lesser frequency.

Most popular intervention types in "Bluewater Clinical Research Group Inc" are "Drug" (35 trials), "Other" (6 trials), "Biological" (5 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Tirzepatide" (4 trials), "ABP-450" (2 trials), "DDP733" (2 trials) and "Dulaglutide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bluewater Clinical Research Group Inc" are 37 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bluewater Clinical Research Group Inc". undefined are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Bluewater Clinical Research Group Inc, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Bluewater Clinical Research Group Inc, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".